It's August. Which means the dog days of the media budget-planning season are upon us again.

Welcome to The Agency Issue 2008—the biggest ever issue of MM&M.

Pharmaceutical marketers spend a lot of time and effort figuring out what makes physicians tick.

One of the fundamental challenges facing pharmaceutical companies is finding a balance between developing and manufacturing lifesaving medications and making money for shareholders.

This is the time of year when we take our annual, in-depth look at direct-to-consumer advertising.

The other day I was flipping through some old copies of the sadly defunct Revolution magazine (for digital marketers) and an editorial from February 2001 caught my eye.

Like the vast majority of kids growing up in England, I was obsessed with soccer.

This time last year we boldly saluted Merck as MM&M's first All-Star Company of the Year.

So how was it for you? 2007, that is.

There hasn't been much good news coming out of Pfizer in the past couple of years. Efforts to replace anticipated losses from the looming patent expirations of Lipitor and other products have taken ghastly and much-publicized turns.